EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Robust prediction of drug combination side effects in realistic settings

Ruben Jimenez iD, Alberto Paccanaro iD

PLOS Computational Biology · 2026

DOI: 10.1371/journal.pcbi.1013619 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Computational Biology, 2026. Verfasst von Ruben Jimenez und 1 weiteren Autor:innen. Beteiligte Einrichtung: Escola de Matemática Aplicada, Fundação Getúlio Vargas, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, Medical Research Council, Consejo Nacional de Ciencia y Tecnología, Paraguay.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Side effects caused by drug combinations pose a major challenge in healthcare. Knowledge of these side effects is limited because often they are not detected in clinical trials, which typically involve a restricted number of participants and tested drug combinations. We introduce DCSE (Drug Combinations Side Effects), a novel machine learning method for predicting polypharmacy side effects. DCSE learns latent signatures for drugs, drug pairs, and side effects to predict the probability that a side effect occurs in a given drug combination. We first evaluate its performance in the commonly adopted experimental settings in the literature. However, these rely on balanced testing datasets and sampled negative examples, which do not capture the highly imbalanced and structured set of unknown side effects encountered in practice. Therefore, a key contribution of this paper is the introduction of more realistic experimental settings under prospective evaluations. Here, we attempt to predict side effects reported between 2009 and 2014 after training only on data available prior to that period. These evaluations include warm-start scenarios, in which some side effects are already known for a drug pair, and cold-start scenarios, in which the model predicts side effects for previously uncharacterized drug pairs. Our results indicate that DCSE consistently outperforms state-of-the-art methods, demonstrating its robustness and efficacy in real-world applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Related Side Effects and Adverse ReactionsHumansMachine LearningComputational BiologyDrug CombinationsPrediction AlgorithmsPredictive Learning ModelsPolypharmacyAlgorithms

Substanzen

Drug Combinations

Autor:innen und Institutionen

  • Escola de Matemática Aplicada, Fundação Getúlio Vargas, Rio de Janeiro, Brazil.
  • Department of Computer Science, Centre for Systems and Synthetic Biology, Royal Holloway University of London, Egham, United Kingdom.

ORCID-Profile: Ruben Jimenez, Alberto Paccanaro

Förderung

  • Biotechnology and Biological Sciences Research Council
  • Medical Research Council
  • Consejo Nacional de Ciencia y Tecnología, Paraguay
  • National Science Foundation
  • Fundacão de Amparo a Pesquisa do Estado do Rio de Janeiro
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação Getulio Vargas

Zitieren

APA

Jimenez, R., & Paccanaro, A. (2026). Robust prediction of drug combination side effects in realistic settings. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1013619

Vancouver

Jimenez R, Paccanaro A. Robust prediction of drug combination side effects in realistic settings. PLOS Computational Biology. 2026. doi:10.1371/journal.pcbi.1013619

BibTeX
@article{Jimenez2026,
  author = {Jimenez, Ruben and Paccanaro, Alberto},
  title = {Robust prediction of drug combination side effects in realistic settings},
  journal = {PLOS Computational Biology},
  year = {2026},
  doi = {10.1371/journal.pcbi.1013619}
}
Kostenlos starten →